Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.
about
Management of endocrine disease: Secondary osteoporosis: pathophysiology and managementThe alliance of mesenchymal stem cells, bone, and diabetesRecognizing and treating secondary osteoporosisSigma Factor SigB Is Crucial to Mediate Staphylococcus aureus Adaptation during Chronic InfectionsManagement of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity.11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excessEndogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice.A systematic review of the evidence that brain structure is related to muscle structure and their relationship to brain and muscle function in humans over the lifecourse.Glucocorticoid-induced osteonecrosis.Pathological fractures in paediatric patients with inflammatory bowel disease.11β-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress.Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review.11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative disease.Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.Glucocorticoids and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblastsEndogenous Glucocorticoids and Bone.Glucocorticoid-induced osteoporosis - a disorder of mesenchymal stromal cells?Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infectionGlucocorticoid-induced osteoporosis and osteonecrosis.Inhibition of 11beta-HSD1 as a novel treatment for the metabolic syndrome: do glucocorticoids play a role?The effects of piper sarmentosum water extract on the expression and activity of 11β-hydroxysteroid dehydrogenase type 1 in the bones with excessive glucocorticoids.Hdac3 Deficiency Increases Marrow Adiposity and Induces Lipid Storage and Glucocorticoid Metabolism in Osteochondroprogenitor CellsSynovial DKK1 expression is regulated by local glucocorticoid metabolism in inflammatory arthritis.Our approach to osteoporosis screening and treatment needs to changeCorrelation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosisLocal and systemic glucocorticoid metabolism in inflammatory arthritis.11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects.Skeletal involvement in adult patients with endogenous hypercortisolism.Regulation of ENaC-mediated sodium transport by glucocorticoids in Reissner's membrane epitheliumBone involvement in exogenous hypercortisolism.Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.The 11beta-hydroxysteroid dehydrogenase enzymes--arbiters of the effects of glucocorticoids in synovium and bone.Corticosteroid-induced osteoporosis: an update for dermatologists.Is there sufficient evidence to consider the use of 11β-hydroxysteroid dehydrogenase type 1 inhibition in children?Management of glucocorticoid-induced osteoporosis.Glucocorticoid metabolism in rheumatoid arthritis.Recent advances in the role of cortisol and metabolic syndrome in age-related degenerative diseases.
P2860
Q26998249-CFDD52AB-4632-4B7B-94F2-7331724614E7Q27012497-858D4361-7E72-4EA7-B48F-8787AE9AD536Q28270738-D6AD2F55-FC76-4DB6-A941-260FCFD3853DQ28546816-8BA351FC-AD54-4411-B05C-B2A1F0354388Q30946308-EB8B19A8-5183-43FD-9B87-6C583EED7382Q33665237-8D413B5E-8C3E-4027-B53D-02E913C6627FQ33789944-879E52A1-C196-4837-9153-B9505B014160Q33806970-A77AA73B-4863-4F9E-B59F-36DD2EC0FCF7Q33929253-B373891A-C5A9-4606-B5E9-00020064CE47Q34240713-BC686FC3-432A-4253-8850-85836C0487EBQ34378165-5F5A9A89-A5AF-4B9E-9D0F-6A72D9A5B16FQ35144168-BEB25555-69B8-4DB3-A210-4EF95682690BQ35210556-32C99EAB-88F6-4868-9C32-FA24EC0D19D0Q35593949-10B492BD-06E5-4BD7-9B07-AC4B2AA11340Q35601856-1AF47835-043F-48B5-8239-8185AE3AFCBAQ35639657-6B176D5C-9C0F-4675-949B-14C8C6CFDC2AQ35755106-097F594A-7B86-4F94-B4A8-94E4FC5A4118Q35972062-7942CCFB-36EA-464D-B2AF-8D2AA715B8E6Q36090341-439E76AA-9AE8-4BA2-ABF2-02A385E31001Q36157622-86A3B315-2A48-4309-9A16-41AA16F47F8EQ36266034-79330C44-E059-4C17-8F3D-D3BCFD5DE5E3Q36314303-D0491A30-779E-4E2C-A2E5-5DA3172C8A9CQ36593452-1464F169-2ECD-4C03-8646-9A280DFAA258Q36633247-2C4C33B0-F7AA-4297-9164-4B5A3FC49769Q36700596-EE59FD72-D74F-46CA-9788-D6D2BA782109Q36929029-A587730E-AD22-4464-BD2D-9FFB03A46637Q36930708-5D773CB8-4A32-4B5B-91F9-99DBA606E115Q36967015-7CDCF007-C287-4E07-9BC3-3A9ABE49D570Q37062092-0BAFBD72-063C-403A-AABA-8F8CA2A55295Q37133892-A3D56E1A-B229-48F2-9A8E-4FAA7A0F57CAQ37139042-3FA61E52-63E0-414D-BDDF-3A8A71E499F3Q37161922-16FA388C-0FF4-4F90-963C-08706FB0B9F6Q37230770-DA59C240-1D19-4353-B3BD-227930B2B5A6Q37655884-91B91404-7026-4A65-90CC-A4272BEFF11FQ37773096-B4D501AD-CEF4-4A02-A6EC-C5057F13A5FEQ37990943-F328C836-E6C5-48AA-83F3-E1A70D140380Q38001047-1AF661F9-3E41-480E-971B-DE27A533DBCEQ38033444-38AC69FC-1551-4B07-816F-CB92448AC8FDQ38192016-B56D9A61-0094-41B7-B089-3A7550210243Q38392643-8C38CC54-2B28-4120-A57B-78A4996BBD87
P2860
Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Osteoblastic 11beta-hydroxyste ...... e and glucocorticoid exposure.
@en
Osteoblastic 11beta-hydroxyste ...... e and glucocorticoid exposure.
@en-gb
type
label
Osteoblastic 11beta-hydroxyste ...... e and glucocorticoid exposure.
@en
Osteoblastic 11beta-hydroxyste ...... e and glucocorticoid exposure.
@en-gb
prefLabel
Osteoblastic 11beta-hydroxyste ...... e and glucocorticoid exposure.
@en
Osteoblastic 11beta-hydroxyste ...... e and glucocorticoid exposure.
@en-gb
P2093
P1476
Osteoblastic 11beta-hydroxyste ...... e and glucocorticoid exposure.
@en
P2093
Elizabeth H Rabbitt
Mark S Cooper
Martin Hewison
Philippa E Goddard
William A Bartlett
P304
P356
10.1359/JBMR.2002.17.6.979
P50
P577
2002-06-01T00:00:00Z